FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1524583364> ?p ?o ?g. }

• W1524583364 endingPage "735" @default.
• W1524583364 startingPage "729" @default.
• W1524583364 abstract "We aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of elderly patients with tyrosine kinase inhibitors (TKI) therapy.Data including the clinical characteristics, therapeutic outcomes and compliance with TKI therapy of elderly patients with chronic myeloid leukemia aged >65 years were collected from 13 institutions in Turkey, retrospectively.A total of 69 patients (27 [39%] men, 42 [61%] women) were evaluated retrospectively. The median age of the patients was 71 years (range 66-85 years). Of the patients, 66 (96%) were in the chronic phase and three (4.3%) were in the accelerated phase when diagnosed. A total of 63 (91.3%) patients were receiving imatinib as the first-line therapy. The initial dose of imatinib was 400 mg/day in 59 patients (93.6%). Imatinib treatment induced 57 (90.5%) complete hematological responses at 3 months, 29 (46%) complete cytogenetic responses at 6 months and 49 (77.7%) major molecular responses at 12 months. As a result, nilotinib and dasatinib were used in 14 patients as second-line therapy. Second-line TKI induced nine complete hematological responses (64.3%) at 3 months, four complete cytogenetic responses (28.6%) at 12 months and seven major molecular responses (50%) at 18 months. A total of 56 of the patients (81.2%) are still alive. The median overall survival and progression-free survival rates were 35 months (range 1-95 months) and 17 months (range 0.8-95 months), respectively.Elderly patients should receive TKI according to the same guidelines that apply to younger patients." @default.
• W1524583364 created "2016-06-24" @default.
• W1524583364 creator A5004484117 @default.
• W1524583364 creator A5006840808 @default.
• W1524583364 creator A5012050692 @default.
• W1524583364 creator A5017641457 @default.
• W1524583364 creator A5020222160 @default.
• W1524583364 creator A5030262886 @default.
• W1524583364 creator A5031256616 @default.
• W1524583364 creator A5037716962 @default.
• W1524583364 creator A5043321497 @default.
• W1524583364 creator A5055141457 @default.
• W1524583364 creator A5059747985 @default.
• W1524583364 creator A5073842545 @default.
• W1524583364 creator A5076365796 @default.
• W1524583364 creator A5076679100 @default.
• W1524583364 creator A5076735212 @default.
• W1524583364 creator A5076943240 @default.
• W1524583364 creator A5082089864 @default.
• W1524583364 creator A5088962433 @default.
• W1524583364 date "2014-09-26" @default.
• W1524583364 modified "2023-10-17" @default.
• W1524583364 title "Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study" @default.
• W1524583364 cites W1963731492 @default.
• W1524583364 cites W1968152930 @default.
• W1524583364 cites W1968351802 @default.
• W1524583364 cites W1968747503 @default.
• W1524583364 cites W1992254924 @default.
• W1524583364 cites W2001289393 @default.
• W1524583364 cites W2006696111 @default.
• W1524583364 cites W2014364674 @default.
• W1524583364 cites W2021648831 @default.
• W1524583364 cites W2028669471 @default.
• W1524583364 cites W2028835250 @default.
• W1524583364 cites W2028959752 @default.
• W1524583364 cites W2042528156 @default.
• W1524583364 cites W2055515709 @default.
• W1524583364 cites W2067635683 @default.
• W1524583364 cites W2068508150 @default.
• W1524583364 cites W2072875377 @default.
• W1524583364 cites W2075706560 @default.
• W1524583364 cites W2079517811 @default.
• W1524583364 cites W2083350897 @default.
• W1524583364 cites W2090128061 @default.
• W1524583364 cites W2097019092 @default.
• W1524583364 cites W2097799776 @default.
• W1524583364 cites W2107268345 @default.
• W1524583364 cites W2117356576 @default.
• W1524583364 cites W2143939343 @default.
• W1524583364 cites W2148743957 @default.
• W1524583364 cites W2156145496 @default.
• W1524583364 doi "https://doi.org/10.1111/ggi.12341" @default.
• W1524583364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25257190" @default.
• W1524583364 hasPublicationYear "2014" @default.
• W1524583364 type Work @default.
• W1524583364 sameAs 1524583364 @default.
• W1524583364 citedByCount "2" @default.
• W1524583364 countsByYear W15245833642016 @default.
• W1524583364 countsByYear W15245833642021 @default.
• W1524583364 crossrefType "journal-article" @default.
• W1524583364 hasAuthorship W1524583364A5004484117 @default.
• W1524583364 hasAuthorship W1524583364A5006840808 @default.
• W1524583364 hasAuthorship W1524583364A5012050692 @default.
• W1524583364 hasAuthorship W1524583364A5017641457 @default.
• W1524583364 hasAuthorship W1524583364A5020222160 @default.
• W1524583364 hasAuthorship W1524583364A5030262886 @default.
• W1524583364 hasAuthorship W1524583364A5031256616 @default.
• W1524583364 hasAuthorship W1524583364A5037716962 @default.
• W1524583364 hasAuthorship W1524583364A5043321497 @default.
• W1524583364 hasAuthorship W1524583364A5055141457 @default.
• W1524583364 hasAuthorship W1524583364A5059747985 @default.
• W1524583364 hasAuthorship W1524583364A5073842545 @default.
• W1524583364 hasAuthorship W1524583364A5076365796 @default.
• W1524583364 hasAuthorship W1524583364A5076679100 @default.
• W1524583364 hasAuthorship W1524583364A5076735212 @default.
• W1524583364 hasAuthorship W1524583364A5076943240 @default.
• W1524583364 hasAuthorship W1524583364A5082089864 @default.
• W1524583364 hasAuthorship W1524583364A5088962433 @default.
• W1524583364 hasConcept C121608353 @default.
• W1524583364 hasConcept C126322002 @default.
• W1524583364 hasConcept C141071460 @default.
• W1524583364 hasConcept C167135981 @default.
• W1524583364 hasConcept C2777413986 @default.
• W1524583364 hasConcept C2777583451 @default.
• W1524583364 hasConcept C2778729363 @default.
• W1524583364 hasConcept C2778820342 @default.
• W1524583364 hasConcept C2779536868 @default.
• W1524583364 hasConcept C3019892230 @default.
• W1524583364 hasConcept C71924100 @default.
• W1524583364 hasConceptScore W1524583364C121608353 @default.
• W1524583364 hasConceptScore W1524583364C126322002 @default.
• W1524583364 hasConceptScore W1524583364C141071460 @default.
• W1524583364 hasConceptScore W1524583364C167135981 @default.
• W1524583364 hasConceptScore W1524583364C2777413986 @default.
• W1524583364 hasConceptScore W1524583364C2777583451 @default.
• W1524583364 hasConceptScore W1524583364C2778729363 @default.
• W1524583364 hasConceptScore W1524583364C2778820342 @default.
• W1524583364 hasConceptScore W1524583364C2779536868 @default.

• next